Skip to content

IMRX - Immuneering Corp - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

Immuneering Corp

IMRX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

IMRXImmuneering Corp

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $10.08
52-wk low: $3.86
Prev close: $6.48
Mkt cap: $344.8M
Beta: 0.37
P/S: 563.6x

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$85.0M

MW
Marshall Wace
Q2 2026 13F
$3.7M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $345M

Valuation

P/S563.62
P/B1.70

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: IMRX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $344.84M
Beta: 0.37

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

1.7x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-52.1%

$1.9M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$1.6M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for IMRX

No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

EPS expected

-$0.32

-$0.37 to -$0.27

Revenue expected

$0.00

8 analysts

Last 30 days

0up1down

Analysts cutting estimates

-52.1%

ROA-32.8%

Growth

Beta0.37